Stig Jarle Pettersen

Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark.

Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway.

Cermaq Group AS engages in aquaculture business. It focuses on the sustainable production of feed to and farming of salmon and trout. The firm operates in the following segments: Fish Farming and Fish Feed. The Fish Farming segment is involved in the breeding and on-growing of salmon and trout, as well as the slaughtering, processing, sale and distribution of such. The Fish Feed segment engages in the production and sale of fish feed. The company was founded in January 1995 and is headquartered in Oslo, Norway.

Actigen Ltd. provides biological products. The private company is based in Cambridge, UK.